Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Coagulation

  • Blood-Thinner Reversal Agent Works in 82% of Serious Bleeding Cases

    Broader results from the ANNEXA-4 trial have confirmed that Portola Pharmaceuticals’ andexanet alfa, sold as Andexxa, can...
  • Coagulation Factor Concentrate Superior for Trauma-Induced Coagulopathy

    Coagulation factor concentrates (CFC) are more effective than fresh frozen plasma (FFP) for reversing trauma-induced coagulopathy, according...
  • What Emergency Physicians Can Do to Reduce Unnecessary Coagulation Testing in Patients with Chest Pain

    Engage other medical specialties and admitting physicians to achieve consensus on tests that are not necessary for...

Blood-Thinner Reversal Agent Works in 82% of Serious Bleeding Cases

March 8, 2019 - Reuters Staff - 1 Comment

Broader results from the ANNEXA-4 trial have confirmed that Portola Pharmaceuticals’ andexanet alfa, sold as Andexxa, can…

Read More

Coagulation Factor Concentrate Superior for Trauma-Induced Coagulopathy

May 22, 2017 - Reuters Staff - 0 Comment

Coagulation factor concentrates (CFC) are more effective than fresh frozen plasma (FFP) for reversing trauma-induced coagulopathy, according…

Read More

What Emergency Physicians Can Do to Reduce Unnecessary Coagulation Testing in Patients with Chest Pain

May 9, 2014 - Michelle Lin, MD, MPH and Jeremiah D. Schuur, MD, MHS - 1 Comment

Engage other medical specialties and admitting physicians to achieve consensus on tests that are not necessary for…

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603